clinical trial · NCT05170334
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute·phase2·active not recruiting·n = 7
Metastatic Uveal MelanomaBinimetinibBelinostat
brief summary
This research study is investigating Binimetinib and Belinostat in participants with metastatic uveal melanoma. The research study will test the study drugs to see if the combination of binimetinib and belinostat can make tumors shrink or stop growing.
started
Dec 15, 2021
primary completion
Dec 1, 2025
completion
Jan 1, 2028
last updated
Apr 6, 2026
official title
A Phase II Study of Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol